Synaffix Licenses Metal-Free Click Chemistry Technology to Illumina for Next-Generation DNA Sequencing Applications
Illumina, Inc. (ILMN)
Last illumina, inc. earnings: 4/30 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
illumina.com/company/investor-information.html
Company Research
Source: PR Newswire
Agreement grants access to Synaffix patent portfolio related to metal-free click chemistryTechnology to be used in Illumina's next-generation sequencing (NGS) products AMSTERDAM, Dec. 4, 2024 /PRNewswire/ -- Synaffix B.V., a Lonza company (SIX:LONN) focused on commercializing its clinical-stage bioconjugation platform technology for the development of antibody-drug conjugates (ADCs) with best-in-class therapeutic index and beyond, today announced it has entered into a licensing agreement with Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies. The agreement grants Illumina access to Synaffix's patented metal-free click chemistry technology.Synaffix's patented metal-free click chemistry will be used in relation to certain Illumina next-generation sequencing (NGS) products.Floris van Delft, Head of Research and Development at Synaffix, said: "At Synaffix, we are deploying a superior probe, bicyclononyne (BCN), for metal-free click chemistry for
Show less
Read more
Impact Snapshot
Event Time:
ILMN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ILMN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ILMN alerts
High impacting Illumina, Inc. news events
Weekly update
A roundup of the hottest topics
ILMN
News
- Macrogen Consortium win tender for National Bio Big Data Project [Yahoo! Finance]Yahoo! Finance
- Macrogen Consortium win tender for National Bio Big Data ProjectPR Newswire
- Ovation.io and Illumina Collaborate to Advance Genomic Data ResearchBusiness Wire
- Is There Now An Opportunity In Illumina, Inc. (NASDAQ:ILMN)? [Yahoo! Finance]Yahoo! Finance
- MicroStrategy, Palantir Added to Nasdaq 100, Moderna Removed [Yahoo! Finance Canada]Yahoo! Finance Canada
ILMN
Earnings
- 11/4/24 - Beat
ILMN
Sec Filings
- 1/2/25 - Form 4
- 12/9/24 - Form 4
- 12/6/24 - Form SC
- ILMN's page on the SEC website